Effective treatment of facial redness caused by atopic dermatitis using intense pulsed light systems.

ABSTRACT

BACKGROUND: Patients with facial atopic dermatitis (AD) experience psychological and social distress. OBJECTIVE: To evaluate the safety and the efficacy of intense pulsed light (IPL) treatment in patients with facial AD. MATERIALS AND METHODS: Eleven patients (9 men, 2 women; aged 14-39) with mild to moderate refractory facial AD were included in this study. In three separate sessions at 2-week intervals, the whole face was exposed to an IPL device using a 590-nm cut-off filter. Objective clinical response was examined using the Eczema Severity Score (ESS), a polarization color imaging system, and two dermatologists' evaluations. Data on quality of life were evaluated using the Dermatology Life Quality Index (DLQI). RESULTS: The ESS in 11 patients with facial AD was significantly lower 4 weeks after the third treatment (p=.005). Scaling (p=.003); edema, induration, and papules (p=.011); erythema (p=.009), and lichenification (p=.008) improved significantly. The erythema scale, examined using the polarization color imaging system, also decreased significantly (p=.04). No patients showed any noticeable side effects. Mean DLQI score improved significantly after the completion of therapy (from baseline to 4 weeks after the last IPL treatment; p=.005). CONCLUSION: IPL treatment could be used as an adjunct modality for the treatment of refractory facial AD with minimal side effects.